Turenne Capital (Turenne Groupe) is a leading independent French small-cap private equity firm based in Paris, founded in 1999. It invests across venture capital, growth capital, and buyout capital, financing SMEs, startups, and mid-market companies throughout France.
30% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $28.3M (across 9 rounds with reported amounts).
Portfolio
16
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
Anne-Sophie MAES
Managing Partner of Nord Capital Partenaires
Antoine PUGET
Managing Partner
Damien GARAU
Managing Partner of Connect Pro
Mounia CHAOUI
Managing Partner – Health
Rémy GARELLO
Managing Partner of Connect Pro
Anne-Laure MEYNIER
Partner
Benjamin WAINSTAIN
Partner
Frédéric HUMBERT
Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Coave Therapeutics | Series A | $33M | Jan 2025 |
 Coave Therapeutics | Series A | $32M | Jan 2025 |
| SSamanTree | Series B | $14M | Jan 2024 |
| SSamanTree Medical SA | Series B | $14M | Jan 2024 |
 ABOLERIS PHARMA | Series A | — | Sep 2023 |
| OOSO-AI | Series A | — | Apr 2023 |
 Therapixel | Series B | — | May 2022 |
 Domain Therapeutics | Series A | $42M | May 2022 |
| Domain Therapeutics | Series A | $42M | Jan 2022 |
 Kainova Therapeutics | Series A | $42M | Jan 2022 |
| OOmbrea | Unknown | — | Sep 2021 |
| OOSO-AI | Unknown | — | Sep 2020 |
| OOSO-AI | Unknown | — | Jan 2020 |
| Domain Therapeutics | Series B | — | Jan 2020 |
 Germitec | Series B | — | — |
| AAViwest | Series B | — | — |
| TTradim | Unknown | $19.7M | — |
| EEcoDrop | Unknown | — | — |
| NNaturopera | Growth | $16M | — |
| SSYDEV | Unknown | — | — |
Top Co-Investors
Last updated: 20 October 2026